Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Our Lady of Lourdes Regional Medical Center is embracing cutting-edge technology to transform how heart conditions are ...

Saint Francis treated its first patient with pulsed-field ablation, which delivers pulsed electric fields to tissue to treat ...

Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

The Ordensklinikum Linz Elisabethinen is one of the first centers worldwide and the first center in Austria to use a new method for the treatment of ...

A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...

A new study is trying to find out why electrical cardioversion (ECV) or shock treatment only works in some patients with atrial fibrillation (AFib), using artificial intelligence. The project ...

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

OptiShot ultra-compliant balloon enables tissue contact and precise anatomic delivery of pulsed energy for treatment of atrial fibrillation in first European patients MARLBOROUGH, Mass.--( ...

29,427 people played the daily Crossword recently. Can you solve it faster than others?29,427 people played the daily Crossword recently. Can you solve it faster than others?